Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IMMUCELL CORP /DE/ Director's Dealing 2010

May 14, 2010

34519_dirs_2010-05-14_37395944-e682-445b-a2d5-47ae79b74c99.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IMMUCELL CORP /DE/ (ICCC)
CIK: 0000811641
Period of Report: 2010-05-12

Reporting Person: ROTHSCHILD JONATHAN E (Director, 10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2010-05-12 Common Stock, par value $0.10 per share P 400 $3.51 Acquired 459370 Direct
2010-05-12 Common Stock, par value $0.10 per share P 100 $3.49 Acquired 459470 Direct
2010-05-12 Common Stock, par value $0.10 per share P 225 $3.50 Acquired 459695 Direct
2010-05-12 Common Stock, par value $0.10 per share P 900 $3.54 Acquired 460595 Direct
2010-05-13 Common Stock, par value $0.10 per share P 255 $3.51 Acquired 460850 Direct
2010-05-12 Common Stock, par value $0.10 per share P 600 $3.55 Acquired 461450 Direct

Footnotes

F1: These shares were acquired by Arterio, Inc., a company solely owned by Mr. Rothschild.

F2: This figure includes 213,855 shares of common stock held by Arterio, Inc., a company solely owned by Mr. Rothschild.